Alison K. Ross

Alison K. Ross

Auto-generated profile, based on publicly available information

Alison K. Ross

Department of Orthopaedic Surgery, Washington University in St. Louis, St. Louis, MO 63110, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
RNRobert J. Nims
Robert J. Nims
LPLara Pferdehirt
Lara Pferdehirt
NHNoelani B. Ho
Noelani B. Ho
ASAlireza Savadipour
Alireza Savadipour
JLJeremiah Lorentz
Jeremiah Lorentz
Farshid GuilakFarshid Guilak
Farshid Guilak
A mechanogenetic system was developed using a synthetic gene circuit to produce biologic drugs in response to mechanical loading.

3 September 2021 in Science Advances
Verified
Journal Article
Open access
YCYun Rak Choi
Yun Rak Choi
Kelsey Helen-Marie CollinsKelsey Helen-Marie Collins
Kelsey Helen-Marie Collins
LSLuke Springer
Luke Springer
LPLara Pferdehirt
Lara Pferdehirt
ARAlison K. Ross
Alison K. Ross
Farshid GuilakFarshid Guilak
Farshid Guilak
Genome editing of stem cells creates a living implant that can produce arthritis-fighting drugs in response to inflammation.

7 August 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
ARAlison K. Ross
Alison K. Ross
RARodrigo Coutinho De Almeida
Rodrigo Coutinho De Almeida
YRYolande F. M. Ramos
Yolande F. M. Ramos
JLJiehan Li
Jiehan Li
IMIngrid Meulenbelt
Ingrid Meulenbelt
Farshid GuilakFarshid Guilak
Farshid Guilak
Osteoarthritis (OA) is a degenerative joint disease, and inflammation within an arthritic joint plays a critical role in disease progression. Pro‐inflammatory cytokines, specifically IL‐1 and TNF‐α, induce aberrant expression of catabolic and degradative enzymes and inflammatory cytokines in OA and result in a challenging environment for cartilage repair and regeneration. MicroRNAs (miRNAS) are small noncoding RNAs and are important regulatory molecules that act by binding to target messenger RNAs (mRNAs) to reduce protein synthesis and have been implicated in many diseases, including OA. The goal of this study was to understand the mechanisms of miRNA regulation of the transcriptome of tissue‐engineered cartilage in response to IL‐1β and TNF‐α using an in vitro murine induced pluripotent stem cell (miPSC) model system. We performed miRNA and mRNA sequencing to determine the temporal and dynamic responses of genes to specific inflammatory cytokines as well as miRNAs that are differentially expressed (DE) in response to both cytokines or exclusively to IL‐1β or TNF‐α. Through integration of mRNA and miRNA sequencing data, we created networks of miRNA‐mRNA interactions which may be controlling the response to inflammatory cytokines. Within the networks, hub miRNAs, miR‐29b‐3p, miR‐17‐5p, and miR‐20a‐5p, were identified. As validation of these findings, we found that delivery of miR‐17‐5p and miR‐20a‐5p mimics significantly decreased degradative enzyme activity levels while also decreasing expression of inflammation‐related genes in cytokine‐treated cells. This study utilized an integrative approach to determine the miRNA interactome controlling the response to inflammatory cytokines and novel mediators of inflammation‐driven degradation in tissue‐engineered cartilage.